197 related articles for article (PubMed ID: 36346099)
1. Time-varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population-based study and meta-analysis.
van der Kruijssen DEW; van der Kuil AJS; Vink GR; Punt CJA; de Wilt JHW; Elias SG; Koopman M
Int J Cancer; 2023 Apr; 152(7):1360-1369. PubMed ID: 36346099
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Effect of Tumor Sidedness in Colorectal Cancer: A SEER-Based Analysis.
Li Y; Feng Y; Dai W; Li Q; Cai S; Peng J
Clin Colorectal Cancer; 2019 Mar; 18(1):e104-e116. PubMed ID: 30448100
[TBL] [Abstract][Full Text] [Related]
3. Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies.
Boeckx N; Koukakis R; Op de Beeck K; Rolfo C; Van Camp G; Siena S; Tabernero J; Douillard JY; André T; Peeters M
Ann Oncol; 2017 Aug; 28(8):1862-1868. PubMed ID: 28449055
[TBL] [Abstract][Full Text] [Related]
4. Interaction Between Primary Tumor Resection, Primary Tumor Location, and Survival in Synchronous Metastatic Colorectal Cancer: A Population-Based Study.
van der Kruijssen DEW; Brouwer NPM; van der Kuil AJS; Verhoeven RHA; Elias SG; Vink GR; Punt CJA; de Wilt JHW; Koopman M
Am J Clin Oncol; 2021 Jul; 44(7):315-324. PubMed ID: 33899807
[TBL] [Abstract][Full Text] [Related]
5. Role of Up-Front Primary Tumor Resection and Tumor Sidedness in the Survival of Synchronous Metastatic Colon Cancer Patients.
van der Kruijssen DEW; van Rooijen KL; Kurk SA; de Wilt JHW; Punt CJA; Vink GR; Elias SG; Koopman M
Dig Surg; 2021; 38(4):283-289. PubMed ID: 34320508
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Primary Tumor Sidedness for Unresectable Stage IV Colorectal Cancer: A Retrospective Study.
Shida D; Tanabe T; Boku N; Takashima A; Yoshida T; Tsukamoto S; Kanemitsu Y
Ann Surg Oncol; 2019 May; 26(5):1358-1365. PubMed ID: 30719633
[TBL] [Abstract][Full Text] [Related]
7. Tumor Sidedness Is Associated with Survival in Patients with Synchronous Colorectal Peritoneal Carcinomatosis.
Matsuda K; Tamura K; Iwamoto H; Mizumoto Y; Mitani Y; Nakamura Y; Murakami D; Sakanaka T; Yamaue H
Oncology; 2020; 98(4):230-236. PubMed ID: 31962336
[TBL] [Abstract][Full Text] [Related]
8. Tumor Sidedness, Recurrence, and Survival After Curative Resection of Localized Colon Cancer.
Malakorn S; Ouchi A; Hu CY; Sandhu L; Dasari A; You YN; Kopetz ES; Ellis LM; Chang GJ
Clin Colorectal Cancer; 2021 Mar; 20(1):e53-e60. PubMed ID: 33004292
[TBL] [Abstract][Full Text] [Related]
9. Primary tumour location affects survival after resection of colorectal liver metastases: A two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score.
Gasser E; Braunwarth E; Riedmann M; Cardini B; Fadinger N; Presl J; Klieser E; Ellmerer P; Dupré A; Imai K; Malik H; Baba H; Ulmer H; Schneeberger S; Öfner D; Dinnewitzer A; Stättner S; Primavesi F
PLoS One; 2019; 14(5):e0217411. PubMed ID: 31150437
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Impact of Primary Tumor Sidedness in Stage III Colorectal Cancer: Real-World Evidence from a Brazilian Cohort.
Protásio BM; de Castria TB; Natalino R; Mangone FR; Saragiotto DF; Sabbaga J; Hoff PM; Chammas R
Clin Colorectal Cancer; 2024 Mar; 23(1):73-84. PubMed ID: 38151358
[TBL] [Abstract][Full Text] [Related]
11. A population-based study on the prognostic impact of primary tumor sidedness in patients with peritoneal metastases from colon cancer.
de Boer NL; Rovers K; Burger JWA; Madsen EVE; Brandt-Kerkhof ARM; Kok NFM; de Wilt JHW; de Reuver PH; Bos A; de Hingh IHJT; Verhoef C
Cancer Med; 2020 Aug; 9(16):5851-5859. PubMed ID: 32614506
[TBL] [Abstract][Full Text] [Related]
12. Association between cigarette smoking and colorectal cancer sidedness: A multi-center big-data platform-based analysis.
Yang LP; Wang ZX; Zhang R; Zhou N; Wang AM; Liang W; Wang ZQ; Luo HY; Wang F; Liu JW; Liu F; Zhang XC; Liu YP; Jin Y
J Transl Med; 2021 Apr; 19(1):150. PubMed ID: 33858440
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of primary tumor location in colorectal cancer: an updated meta-analysis.
Gholamalizadeh H; Zafari N; Velayati M; Fiuji H; Maftooh M; Ghorbani E; Hassanian SM; Khazaei M; Ferns GA; Nazari E; Avan A
Clin Exp Med; 2023 Dec; 23(8):4369-4383. PubMed ID: 37405571
[TBL] [Abstract][Full Text] [Related]
14. The Significance of Sidedness in Patients with Metastatic Colorectal Cancer Treated with Triplet First-line Chemotherapy.
Bazarbashi S; Omar AT; Raddaoui L; Badran A; Alzahrani A; Aljubran A; Elhassan T
Asian Pac J Cancer Prev; 2019 Oct; 20(10):2891-2896. PubMed ID: 31653131
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta-analysis.
Bylsma LC; Gillezeau C; Garawin TA; Kelsh MA; Fryzek JP; Sangaré L; Lowe KA
Cancer Med; 2020 Feb; 9(3):1044-1057. PubMed ID: 31856410
[TBL] [Abstract][Full Text] [Related]
16. Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).
Benavides M; Gómez-España A; García-Alfonso P; González CG; Viéitez JM; Rivera F; Safont MJ; Abad A; Sastre J; Valladares-Ayerbes M; Carrato A; González-Flores E; Robles L; Salud A; Alonso-Orduña V; Montagut C; Asensio E; Díaz-Rubio E; Aranda E;
Eur J Surg Oncol; 2022 May; 48(5):1123-1132. PubMed ID: 34872775
[TBL] [Abstract][Full Text] [Related]
17. Tumor sidedness is not an independent prognostic marker of colorectal cancer patients undergoing curative resection: A retrospective cohort study.
Chan JCY; Diakos CI; Engel A; Chan DLH; Pavlakis N; Gill A; Clarke SJ
PLoS One; 2019; 14(6):e0218207. PubMed ID: 31188892
[TBL] [Abstract][Full Text] [Related]
18. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
Ben-Aharon I; Goshen-Lago T; Sternschuss M; Morgenstern S; Geva R; Beny A; Dror Y; Steiner M; Hubert A; Idelevich E; Shulman K; Mishaeli M; Man S; Liebermann N; Soussan-Gutman L; Brenner B
Oncologist; 2019 Aug; 24(8):e696-e701. PubMed ID: 30755502
[TBL] [Abstract][Full Text] [Related]
19. Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).
Huemer F; Thaler J; Piringer G; Hackl H; Pleyer L; Hufnagl C; Weiss L; Greil R
BMC Cancer; 2018 Jan; 18(1):11. PubMed ID: 29298682
[TBL] [Abstract][Full Text] [Related]
20. The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials.
Holch JW; Ricard I; Stintzing S; Modest DP; Heinemann V
Eur J Cancer; 2017 Jan; 70():87-98. PubMed ID: 27907852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
